Leibniz-FMP and Humboldt Universität Berlin, Germany
Christian Hackenberger studied chemistry at the Universität Freiburg and the UW Madison/Wisconson and performed his doctoral studies at the RTWH Aachen. After a postdoctoral stay at MIT, he started his group at the Freie Universität Berlin in 2005 as an Emmy Noether fellow. In 2012, he became Leibniz-Humboldt Professor for Chemical Biology at the Leibniz-Research Institute for Molecular Pharmacology and the Humboldt Universität zu Berlin. His group develops chemical strategies to functionalize proteins and antibodies, in particular using chemoselective Staudinger reactions and electrophilic P(V)-reagents, to generate protein-based pharmaceuticals against cancer, Alzheimer and viral infections. He is a co-founder of the company Tubulis, which engineers better tolerable cancer drugs using technologies from his lab.